Goldman Sachs Increases Price Target on FibroGen to $16 From $9, Maintains Sell Rating
Goldman Sachs Increases Price Target on FibroGen to $16 From $9, Maintains Sell Rating
高盛將纖維原的目標價格從 9 美元提高至 16 美元，保持銷售評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊